NovaBay Pharmaceuticals (NBY) has had the highest return since January 1, 2025 by a small-cap US stock, returning 1,259%.
| ASSET | % RETURN |
|---|---|
NovaBay Pharmaceuticals (NBY) | 1,258.97% |
Diginex Limited Ordinary Shares (DGNX) | 1,210.8% |
Zepp Health (ZEPP) | 967.69% |
Palvella Therapeutics (PVLA) | 759% |
Relmada Therapeutics (RLMD) | 738.47% |
DeFi Development (DFDV) | 665.34% |
Hycroft Mining (HYMC) | 626.55% |
Nanobiotix (NBTX) | 611.58% |
Avino Silver & Gold Mines (ASM) | 605.49% |
DBV Technologies (DBVT) | 591.79% |
Newegg Commerce (NEGG) | 579.38% |
AXT (AXTI) | 559.91% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 515.02% |
Rich Sparkle Holdings Limited Ordinary Shares (ANPA) | 493.06% |
Almonty Industries Inc Common Shares (ALM) | 487.5% |
Americas Silver (USAS) | 482.11% |
Inhibrx Biosciences (INBX) | 462.57% |
Nutex Health (NUTX) | 436.78% |
ThredUp (TDUP) | 419.44% |
Village Farms International (VFF) | 418.04% |
Integra Resources (ITRG) | 401.14% |
Resolute Holdings Management (RHLD) | 400.25% |
I-Mab (IMAB) | 392.94% |
Invivyd (IVVD) | 389.36% |
Alto Neuroscience (ANRO) | 364.65% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
